April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Establishment of a reliable laser-Induced Choroidal Neovascularization Animal Model
Author Affiliations & Notes
  • Jean-Antoine C. Pournaras
    Vitreoretinal Surgery Unit,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • Mayte Cachafeiro
    Unit of Gene Therapy & Stem Cell Biology,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • Vérène Pignat
    Unit of Gene Therapy & Stem Cell Biology,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • Yvan Arsenijevic
    Unit of Gene Therapy & Stem Cell Biology,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • Footnotes
    Commercial Relationships  Jean-Antoine C. Pournaras, None; Mayte Cachafeiro, None; Vérène Pignat, None; Yvan Arsenijevic, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 944. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jean-Antoine C. Pournaras, Mayte Cachafeiro, Vérène Pignat, Yvan Arsenijevic; Establishment of a reliable laser-Induced Choroidal Neovascularization Animal Model. Invest. Ophthalmol. Vis. Sci. 2011;52(14):944.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Pathologic choroidal neovascularizations (CNV) are implicated in the wet form of age-related macular degeneration (ARMD). Abnormal vessel growth is also observed in disease when hypoxia and/or inflammation occur. Our goal is to establish a standard protocol of laser-induced CNV in mice that have different levels of pigmentation to identify the most reliable animal model.

Methods: : CNV was induced by 4 burns around the optic disk, using a green argon laser (100µm diameter spot size; 0,05 sec. duration) in C57/Bl6, DBA/1 and Balb/c to ascertain the efficacy of the method in function of retina pigmentation. Five different intensities were tested and Bruch’s membrane disruption was identified by the appearance of a bubble at the site of photocoagulation. Fluorescein angiographies (FA) were undertaken 14 days post lesion and CNV area was quantified by immunohistochemistry on cryosections.

Results: : CNV retina area was related to spot intensity after laser injury. While 180mW and 200mW do not induce reliable CNV (respectively 27.85±0.35% and 29±1.67% of the retina surface), 260mW is required to induce 51,07±8.52% of CNV in C57/Bl6 mice. For the DBA/1 strain, less pigmented, 200mW was sufficient to induce 49.35±3.9% of CNV, indicating that lower intensity are required to induce CNV. Furthermore, an intensity of 180mW induced greater CNV (35.55±6.01%) than in C57/Bl6 mice. Nevertheless, laser did not induce reproducible 50% CNV in Balb/c albino mice for all intensities tested. Isolectin-B4 and GFAP stainings revealed neovessel formation and photoreceptor (PR) degeneration at the impact site. The presence of glia was observed throughout all the retinal layers and angiograms showed fluorescein leakage in pigmented mice.

Conclusions: : The establishment of a standard protocol to induce CNV and subsequent PR degeneration is of prime importance for the use of the laser-induced CNV model and will allow to evaluate the therapeutic potency of agents to prevent CNV and retinal degeneration.

Keywords: age-related macular degeneration • retinal neovascularization • pathology: experimental 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×